SCHEMBL26764112

SCHEMBL26764112

COc1ccc(CNC(=O)NC2CC3(C2)CC(C(=O)N2CCCC2c2ccncc2)C3)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ ALDH1A1 P00352 4/20 0.46
▸ HTT P42858 1/20 0.45
▸ HRH3 Q9Y5N1 2/20 0.45
▸ MCHR1 Q99705 2/20 0.45
▸ EPHX1 P07099 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.43
▸ ADAM17 P78536 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ LMNA P02545 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ PPID Q08752 1/20 0.41
▸ TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26633877 0.92 NPC1 (0.53) SMN1; SMN2NPC1RAB9AALDH1A1HRH3
SCHEMBL30634168 0.92 LMNA (0.53) SMN1; SMN2NPC1RAB9AALDH1A1HRH3
SCHEMBL30288085 0.92 LMNA (0.53) SMN1; SMN2NPC1RAB9AALDH1A1HRH3
SCHEMBL26633844 0.92 LMNA (0.53) SMN1; SMN2NPC1RAB9AALDH1A1HRH3
SCHEMBL26633838 0.92 LMNA (0.53) SMN1; SMN2NPC1RAB9AALDH1A1HRH3
SCHEMBL24011598 0.90 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AALDH1A1HTT
SCHEMBL26633709 0.87 NPC1 (0.52) SMN1; SMN2NPC1RAB9AALDH1A1HRH3
SCHEMBL24011472 0.82 NPC1 (0.58) SMN1; SMN2NPC1RAB9AALDH1A1HRH3
SCHEMBL24011343 0.82 LMNA (0.55) SMN1; SMN2NPC1RAB9AALDH1A1HRH3
SCHEMBL26764099 0.80 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115843295-B NAMPT modulators 赛特凯恩蒂克公司 2025-04-15 — — CN disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
CN-115843295-A NAMPT modulators 赛特凯恩蒂克公司 2023-03-24 — — CN disclosed
EP-4146640-A2 NAMPT MODULATORS Cytokinetics, Inc. (US) 2023-03-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT SMN1; SMN2 610/4885NPC1 128/4885RAB9A 814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback